ACEF II Risk Score for Cardiac Surgery
Predicts 30-day mortality after elective or emergency cardiac surgery using simple preoperative variables.
Score interpretation
ACEF II ≤ 1: Low predicted 30-day mortality (< 1%).
→ Proceed with planned surgery. Standard cardiac surgical care.
ACEF II 1–2: Intermediate predicted 30-day mortality (1–3%).
→ Optimise preoperative status. Detailed informed consent regarding surgical risk.
ACEF II > 2: High predicted 30-day mortality (> 3%).
→ MDT discussion. Consider alternative percutaneous interventions. Detailed consent.
Interpretation bands for the ACEF II. Apply clinical judgement and local guidance.
References
- Ranucci M et al. The ACEF II Risk Score for cardiac surgery: updated but still parsimonious. Eur Heart J. 2018;39(23):2183-2189.
Related
Curated clinical cross-links plus same-class fallbacks.
- Protamine Sulphate (Heparin Reversal) · Heparin Reversal / Cardiac Surgery
- Aprotinin · Antifibrinolytic — Cardiac Surgery
- Protamine Sulphate · Heparin Antidote — Vascular / Cardiac Surgery
- Lidocaine IV (Cardiac Arrhythmia) · Antiarrhythmic
- Mavacamten · Cardiac myosin inhibitor
- Potassium Iodide / Lugol's Solution · Thyroid Blocking Agent / Pre-operative Thyroid Preparation
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.